Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02433665 · ClinicalTrials.gov registry record · NA
Customized Contrast Media Dose Clinical Trial
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 166
- Enrollment target
NCT02433665 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 166 participants.
The verdict
NCT02433665, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 166 participants
- Enrollment target
Study Summary
1. To determine if a formula derived from PCA using specific patient parameters can be used to determine the individual contrast material dose and provide a more consistent level of vascular and parenchymal enhancement during MDCT scanning of the abdomen and pelvis. 2. Up to 500 adult patients referred for a "CT of the abdomen and pelvis with contrast material" will be recruited to participate in this trial. Single CT axial slices (n=2) will be obtained at the level of the L4 pedicle and the supra-acetabular pelvis using a field-of-view that includes all of the patient. From patient measurements (height, weight, body dimensions), a customized dose of contrast material will be specified according to the derived formula for 400 subjects. One hundred subjects will receive the usual fixed contrast dose. 3. Enhancement data in HU will be measured from the CT scans using manually-placed ROIs on the upper abdominal aorta, main portal vein and liver parenchyma, avoiding visible liver tumors, major blood vessels and artifacts, if present. This enhancement data will be used to determine the patient-to-patient variability.
Interventions
- DRUG Iopamidol
- DEVICE Mydose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-10-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02433665
The ClinicalTrials.gov registry entry for NCT02433665 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Iopamidol is the first listed.
NCT02433665 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02433665 about?
NCT02433665 is a clinical study titled "Customized Contrast Media Dose Clinical Trial". 1. To determine if a formula derived from PCA using specific patient parameters can be used to determine the individual contrast material dose and provide a more consistent level of vascular and parenchymal enhancement during MDCT scanning of the abdomen and pelvis. 2. Up to 500 adult patients refer...
What is the current status of trial NCT02433665?
This trial is currently terminated. It is a NA study. The enrollment target is 166 participants. The study started on 2015-08. Estimated completion is 2016-10-06.
What interventions are being tested in trial NCT02433665?
The interventions under investigation include: Iopamidol (DRUG), Mydose (DEVICE).
Who is sponsoring clinical trial NCT02433665?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.